SUMMARY Serum from 74 female and 170 male patients with gonorrhoea and from 72 male and 123 female controls was tested for its ability to induce in gonococci resistance to complement mediated killing by human serum. We confirmed two findings of a previous survey: firstly, a higher precentage of serum samples from women suffering their first infection than from female controls induced high resistance; secondly, no serum sample taken from infected women with complications (mainly salpingitis) induced high resistance. The number of serum samples from female patients with repeat infection was too small for conclusions to be drawn. In men, however, there were no significant differences between patients and controls, or between patients with first or repeat infection, in the percentage whose serum induced high resistance. The pattern of these results on the induction of resistance to serum correlates with the general clinical aspects of gonococcal infections; namely, wide clinical differences in symptoms in women contrasting with a more uniform pattern in men.
Introduction
The resistance of Neisseria gonorrhoeae to complement mediated killing by fresh human serum is considered to be important in the pathogenesis of gonorrhoea.' In many strains of gonococci, this resistance is lost when they are subcultured in the laboratory.' We have been investigating the factors that induce resistance in vivo and their relevance to infection.' A laboratory cultured strain of N gonorrhoeae which was sensitive to serum, BS4 (agar), was initially induced to resist serum by growing it in plastic chambers implanted subcutaneously in guinea pigs; and, subsequently, by incubating it for three hours at 37°C in a medium containing guinea pig serum or its low molecular weight fractions.' Evidence that the induction of resistance may be important in human disease was provided by showing: (a) the presence in human serum of a resistance inducing factor similar to that of the guinea pig2; (b) the ability of male and female genital secretions to induce re-sistance to serum3; and (c) the ability of the low molecular weight fraction of guinea pig serum to induce resistance to serum in all of 30 recent isolates of N gonorrhoeae.4 In a previous survey of correlations between the ability to induce resistance and the existence of gonococcal infections in 50 men and 50 women, there was no appreciable difference between serum samples taken from the patients and those from an equal number of controls.5 Examination of the results of that study in relation to the type of gonococcal infection, however, showed: that serum from female patients with complications (salpingitis), or repeat infection, or both, did not induce resistance; that serum from female patients with their first gonococcal infection induced higher resistance in gonococci than serum from controls; and that serum from male patients with repeat infection induced higher resistance than serum from controls. Chlamydia trachomatis. There were two groups of patients, those suffering a first infection, and those suffering a repeat infection. A third group among the women was those with complications (salpingitis, and in one woman additional perihepatitis). Two of the women with repeat infection also had complications, as did three in our previous report.5 TEST 
FOR INDUCTION OF RESISTANCE TO SERUM
The gonococcal strain BS4 (agar) and the methods of inducing resistance and measuring its extent were as described previously.5 6 Serum was separated and all serum samples were tested twice after freezing and thawing as before.2 5 
STATISTICAL ANALYSIS
Results were analysed by the x2 test, with Yates's correction for small numbers (less than 10). Table I shows the results of this study, which confirmed those of the previous report in two respects: a larger percentage of the serum samples that induced high resistance (that is, that converted more than 50% of the test gonococci to resistance) came from women with a first infection (28%) than from the female controls (20%). None of the six female patients who had complications had serum that induced high resistance. A larger percentage of serum samples that induced high resistance came from women with repeat infection (240/) than from the female controls (20%o). This contrasted with the absence of such activity in the 11 samples from women with repeat infection in the previous survey.5 Furthermore, a lower percentage of serum samples that induced high resistance came from men with a repeat infection (25%) than from men suffering their first infection (35%o) and from control men (28%o), Induction by human serum of resistance to serum in Neisseria gonorrhoeae patients with first infections, although the results for serum from controls (18%) was not significantly different (x2 2-9, p>0 05). As with results from the individual studies, the combined results for female patients with repeat infections (14% of serum samples inducing high resistance) showed no significant differences from the results of the other female groups; and there were no significant differences between the combined results of any of the male groups.
Results

Discussion
The most important conclusion from the combined results of both surveys was the significant differences between the serum samples of the three groups of female patients, as well as between the group with first infections and controls. A somewhat surprising result in the previous survey has been confirmed by this study. The serum from female patients with complications of gonococcal infection did not induce high resistance and, despite the small numbers of such patients (13 in all), this was significantly different from the results for serum samples from patients with their first infections. The fact that the difference in the combined results between serum from patients with complications and from controls is still not significant by the statistical analysis used, should not weigh heavily. Significant differences would almost certainly have been obtained if more serum from patients with complications had been examined because, in two independent surveys, no serum samples from the patients with complications induced high resistance, in contrast with 16% and 18% of the control serum sample. The possible reasons for this reverse correlation between complicated gonococcal infection and the presence of serum that induces high resistance have been discussed previously5 and will be investigated in future work. Again, an examination of the genital secretions of such patients would be an interesting start to such investigations. The indication from the first study that there was also a reverse correlation in women patients between repeat infection and serum that induced high resistance was not confirmed by the second survey or by analysis of the combined results. In view of the diversity between the results of the two surveys in this respect, no conclusions could be drawn without conducting many more tests.
